These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2892410)

  • 1. Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonists.
    Black M
    Am J Med; 1987 Dec; 83(6A):68-75. PubMed ID: 2892410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic effects of drugs used in the treatment of peptic ulcer disease.
    Lewis JH
    Am J Gastroenterol; 1987 Oct; 82(10):987-1003. PubMed ID: 2889354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of H2 receptor antagonists on the hepatotoxicity of various chemicals.
    Leonard TB; Dent JG
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):375-88. PubMed ID: 6147001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.
    Mitchell MC; Schenker S; Speeg KV
    J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions and interactions with H2-receptor antagonists.
    Penston J; Wormsley KG
    Med Toxicol; 1986; 1(3):192-216. PubMed ID: 2878343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.
    Fisher AA; Le Couteur DG
    Drug Saf; 2001 Jan; 24(1):39-57. PubMed ID: 11219486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of H2-receptor antagonists on acetaminophen-induced hepatic injury.
    Murase T; Hazama H; Okuno H; Shiozaki Y; Sameshima Y
    Jpn J Pharmacol; 1986 Aug; 41(4):467-73. PubMed ID: 3773340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematological adverse effects of histamine H2-receptor antagonists.
    Aymard JP; Aymard B; Netter P; Bannwarth B; Trechot P; Streiff F
    Med Toxicol Adverse Drug Exp; 1988; 3(6):430-48. PubMed ID: 2905759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically important adverse effects and drug interactions with H2-receptor antagonists: an update.
    Sax MJ
    Pharmacotherapy; 1987; 7(6 Pt 2):110S-115S. PubMed ID: 2895455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine-acetaminophen interaction: effects on acetaminophen-induced hepatotoxicity in Fischer 344 rats.
    Leonard TB; Morgan DG; Dent JG
    Hepatology; 1985; 5(3):480-7. PubMed ID: 3997076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cimetidine and ranitidine on hepatic drug metabolism.
    Breen KJ; Bury R; Desmond PV; Mashford ML; Morphett B; Westwood B; Shaw RG
    Clin Pharmacol Ther; 1982 Mar; 31(3):297-300. PubMed ID: 6120774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic.
    Rendić S
    Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.
    Powell JR; Donn KH
    Am J Med; 1984 Nov; 77(5B):57-84. PubMed ID: 6150639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible cholestatic injury from ranitidine with a review of the literature.
    Ramrakhiani S; Brunt EM; Bacon BR
    Am J Gastroenterol; 1998 May; 93(5):822-6. PubMed ID: 9625136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acetaminophen and cocaine hepatotoxicity in mice by cimetidine treatment.
    Peterson FJ; Knodell RG; Lindemann NJ; Steele NM
    Gastroenterology; 1983 Jul; 85(1):122-9. PubMed ID: 6852446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.